Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

Abstract Objective To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serv...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2019-12-01
coleção:	Arthritis Research & Therapy
Assuntos:	Calprotectin S100A8/A9 MRP8/14 Rheumatoid arthritis Disease activity
Acesso em linha:	https://doi.org/10.1186/s13075-019-2064-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!